arecoline has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksentijevich, S; Bagdy, G; Bernardini, R; Calogero, AE; Chrousos, GP; Gold, PW; Smith, C; Sternberg, EM; Wilder, RL | 1 |
1 other study(ies) available for arecoline and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Amphetamines; Animals; Arecoline; Corticosterone; Corticotropin-Releasing Hormone; Female; Hypothalamus; Inflammation; Methoxamine; Neurotransmitter Agents; Pituitary Gland; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Adrenergic, alpha; Receptors, Muscarinic; Receptors, Serotonin | 1992 |